Global Traditional Chinese Medicine Compound Preparation Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Traditional Chinese Medicine Compound Preparation Market Insights, Forecast to 2034
Traditional Chinese Medicine (TCM) compound preparations refer to formulations or prescriptions that consist of multiple TCM ingredients. These compound preparations are carefully selected and combined based on TCM principles to achieve specific therapeutic effects and address various health conditions.
Market Analysis and InsightsGlobal Traditional Chinese Medicine Compound Preparation Market
Global Traditional Chinese Medicine Compound Preparation market is expected to reach to US$ 1050 million in 2024, with a positive growth of %, compared with US$ 991 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Traditional Chinese Medicine Compound Preparation industry is evaluated to reach US$ 1407.1 million in 2034. The CAGR will be 5.0% during 2024 to 2034.
Globally, Traditional Chinese Medicine Compound Preparation key companies include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Traditional Chinese Medicine Compound Preparation were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the share will be % in 2034. Moreover, China, plays a key role in the whole Traditional Chinese Medicine Compound Preparation market and estimated to attract more attentions from industry insiders and investors.
Traditional Chinese Medicine Compound Preparation can be divided into Herbal Decoctions, Pills and Tablets, Powders and Capsules, etc. Herbal Decoctions is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2034.
Traditional Chinese Medicine Compound Preparation is widely used in various fields, such as Disease Management, Symptom Relief, Health Promotion and Individualized Treatment, etc. Disease Management provides greatest supports to the Traditional Chinese Medicine Compound Preparation industry development. In 2022, global % revenue of Traditional Chinese Medicine Compound Preparation went into Disease Management filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Traditional Chinese Medicine Compound Preparation market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Traditional Chinese Medicine Compound Preparation market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Segment by Type
Herbal Decoctions
Pills and Tablets
Powders
Capsules
Syrups and Elixirs
Disease Management
Symptom Relief
Health Promotion
Individualized Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, Traditional Chinese Medicine Compound Preparation introduction, etc. Traditional Chinese Medicine Compound Preparation Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12QYResearch’s Conclusions of Traditional Chinese Medicine Compound Preparation
Chapter 13Methodology and Data Sources adopted by QYResearch
Market Analysis and InsightsGlobal Traditional Chinese Medicine Compound Preparation Market
Global Traditional Chinese Medicine Compound Preparation market is expected to reach to US$ 1050 million in 2024, with a positive growth of %, compared with US$ 991 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Traditional Chinese Medicine Compound Preparation industry is evaluated to reach US$ 1407.1 million in 2034. The CAGR will be 5.0% during 2024 to 2034.
Globally, Traditional Chinese Medicine Compound Preparation key companies include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Traditional Chinese Medicine Compound Preparation were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the share will be % in 2034. Moreover, China, plays a key role in the whole Traditional Chinese Medicine Compound Preparation market and estimated to attract more attentions from industry insiders and investors.
Traditional Chinese Medicine Compound Preparation can be divided into Herbal Decoctions, Pills and Tablets, Powders and Capsules, etc. Herbal Decoctions is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2034.
Traditional Chinese Medicine Compound Preparation is widely used in various fields, such as Disease Management, Symptom Relief, Health Promotion and Individualized Treatment, etc. Disease Management provides greatest supports to the Traditional Chinese Medicine Compound Preparation industry development. In 2022, global % revenue of Traditional Chinese Medicine Compound Preparation went into Disease Management filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Traditional Chinese Medicine Compound Preparation market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Traditional Chinese Medicine Compound Preparation market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Segment by Type
Herbal Decoctions
Pills and Tablets
Powders
Capsules
Syrups and Elixirs
Segment by Application
Disease Management
Symptom Relief
Health Promotion
Individualized Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, Traditional Chinese Medicine Compound Preparation introduction, etc. Traditional Chinese Medicine Compound Preparation Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12QYResearch’s Conclusions of Traditional Chinese Medicine Compound Preparation
Chapter 13Methodology and Data Sources adopted by QYResearch
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices